ARCEDI’s mission is to provide pregnant women with a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating fetal cells from maternal blood for genomic analysis of the fetus

ARCEDI Biotech ApS is a Danish biotech company involved in developing technologies for cell based noninvasive prenatal diagnosis (cbNIPD).

ARCEDI Biotech has proprietary method to enrich fetal cells from circulating maternal blood with high efficiency. Once enriched, the fetal cells can be utilized for downstream analysis using technologies such as FISH, array CGH, Next Generation Sequencing, etc. for the detection of chromosomal and subchromosomal changes in the fetal genome.


Anne-Marie Bruun

Laboratory Operations Manager

Anne Katrine Rasmussen

Laboratory Technologist

John Riis Mortensen

Chief Financial Officer

Christina Strande Sønderskov

Laboratory Technologist

Bolette Nicolaisen

Quality Assurance Manager, MSc

Emmeli Mikkelsen

PhD Student

Inga B Christensen

Chief Operating Officer, PhD

Mads Tang Dalsgaard

Chief Executive Officer, PhD

Katarina Ravn

Laboratory Director, Cand. Polyt

Line Dahl Jeppesen

Clinical Application Specialist, PhD

Lotte Hatt

Chief Scientific Officer, PhD

Lotte Munkholm Hansen

Laboratory Technologist

Maiken Bruun Kristensen

Laboratory Technologist

Mathias Kølvraa

Chief Information Officer

Mette Overgaard

Laboratory Technologist

Rie Warghede Kyndesen

Laboratory Technologist

Maria Bach Laursen

Sr. Clinical Genomics Specialist, PhD

Ripudaman Singh

Chief Technology Officer, PhD, MBA

Simone Klavsen

Laboratory Technologist

Gitte Brix

Laboratory Technologist

Maibritt Nørgaard Lauridsen

Clinical Genomics Specialist, PhD

Marlene Christina Nielsen

Molecular Biologist, PhD

Janne No Nielsen

HR Consultant

Morten Muhlig

Bioinformatician, PhD


Our vision is to fundamentally transform prenatal diagnostics by making cell-free non-invasive prenatal testing (cfNIPT), chorionic villus sampling (CVS) and amniocentesis (Amnio) obsolete.


Our mission is to provide pregnant women a safe, simple and accurate cell-based non-invasive prenatal diagnosis (cbNIPD) by isolating and extracting fetal calls from maternal blood for genomic analysis of the fetus.


Aarhus University Hospital

The EVITA TEST has been developed in close collaboration with the Department for Ultrasound/Department for Obstetrics and Gynecology and the Department of Clinical Genetics at the Aarhus University Hospital. The scientific collaboration has evolved since 2005 and fundamentally contributed to the achievement of several milestones and results in the research.

Palle Juul-Jensens Boulevard 99
8200 Aarhus N, Denmark

Bagger-Sørensen & Co. A/S

Since 2013 Bagger-Sorensen & Co. A/S has been financial partner in ARCEDI Biotech. Bagger-Sorensen & Co. A/S is the holding and investment company of the Bagger-Sorensen family based in Vejle, Denmark.

Tabletvej 1
7100 Vejle, Denmark